Zymeworks (ZYME) Prepaid Assets (2021 - 2026)
Zymeworks (ZYME) posted Prepaid Assets of $16.3 million for Q1 2026, up 6.18% sequentially from $15.3 million in Q4 2025, and down 1.85% YoY from $16.6 million in Q1 2025.
Analysis
Zymeworks (ZYME) Prepaid Assets (2021 - 2026) Analysis & Trends
Zymeworks has reported Prepaid Assets for 6 years, with the latest figure at $16.3 million in Q1 2026.
- Quarterly Prepaid Assets fell 1.85% year-over-year to $16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (down 1.85% YoY) and the FY2025 annual result came in at $15.3 million, down 18.71% from the prior year.
- Prepaid Assets improved to $16.3 million in Q1 2026 per ZYME's latest filing, from $15.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $31.4 million in Q2 2023 and troughed at $10.4 million in Q3 2025.
- A 5-year average of $18.0 million and a median of $17.8 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets jumped 91.26% in 2024, then sank 54.4% in 2025.
- Over 5 years, Prepaid Assets stood at $19.1 million in 2022, then advanced by 0.25% to $19.1 million in 2023, then dropped by 1.37% to $18.9 million in 2024, then decreased by 18.71% to $15.3 million in 2025, then rose by 6.18% to $16.3 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $16.3 million, $15.3 million, and $10.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Zymeworks | 2.13 Bn | 1.86 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.76 Mn |
| Mar 31, 2026 | 16.28 Mn |
| Dec 31, 2025 | 15.33 Mn |
| Sep 30, 2025 | 10.43 Mn |
| Jun 30, 2025 | 12.12 Mn |
| Mar 31, 2025 | 16.59 Mn |
| Dec 31, 2024 | 18.86 Mn |
| Sep 30, 2024 | 22.87 Mn |
| Jun 30, 2024 | 21.27 Mn |
| Mar 31, 2024 | 17.82 Mn |
| Dec 31, 2023 | 19.12 Mn |
| Sep 30, 2023 | 11.96 Mn |
| Jun 30, 2023 | 31.43 Mn |
| Mar 31, 2023 | 18.67 Mn |
| Dec 31, 2022 | 19.07 Mn |
| Sep 30, 2022 | 17.69 Mn |
| Dec 31, 2021 | 20.00 Mn |